Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds 35004487 / LU1540961916

120.63 EUR
-6.92 EUR
-5.43 %
15.11.2024
NAV

Nettoinventarwert (NAV)

120.63 EUR -6.92 EUR -5.43 %
Vortag 127.55 EUR Datum 15.11.2024

HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 367.15%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Stellar ETP CH1109575535 216.44%
21Shares Cardano ETP CH1102728750 207.61%
21Shares Sui Staking ETP CH1360612159 144.26%
21Shares Aave ETP CH1135202120 134.46%
21Shares Injective Staking ETP CH1360612134 10.65%
21Shares Immutable ETP CH1360612142 -11.92%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 475.30%
21Shares Aave ETP CH1135202120 332.51%
21Shares Stellar ETP CH1109575535 244.32%
21Shares Cardano ETP CH1102728750 209.77%
21Shares Stacks Staking ETP CH1258969042 145.10%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 323.11%
21Shares Aave ETP CH1135202120 232.41%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 181.47%
21Shares Stellar ETP CH1109575535 144.11%
21Shares Crypto Mid-Cap Index ETP CH1130675676 131.62%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’596.10%
21Shares Ripple XRP ETP CH0454664043 585.99%
21Shares Aave ETP CH1135202120 494.88%
21Shares Bitcoin Core ETP CH1199067674 476.42%
21Shares Bitcoin ETP CH0454664001 461.88%

Fundamentaldaten

Valor 35004487
ISIN LU1540961916
Emittent HBM Partners
Aufgelegt in Luxembourg
Auflagedatum 28.04.2017
Kategorie Branchen: Andere Sektoren
Währung EUR
Volumen 17’853’682.26
Depotbank Pictet & Cie (Europe) S.A. (Luxembourg)
Geschäftsjahresende 31.12.
Berichtsstand 06.01.2025

Anlagepolitik

So investiert der HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds: The investment objective of the Sub-Fund is to achieve long-term capital growth. The goal is to generate a value trend that exceeds the performance of the NASDAQ Biotechnology Index (the “Benchmark”). No guarantee can be given that the investment objective will be achieved.

ETP Performance: HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund A Cap EUR Fonds

Performance 1 Jahr
22.08
Performance 2 Jahre
10.74
Performance 3 Jahre
-8.47
Performance 5 Jahre
14.32
Performance 10 Jahre -